您当前的位置：
首页 >
文章列表页 >
Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients
Short communication | 更新时间：2022-08-11

    • Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients

    • Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients

    • Genes & Diseases   2022年9卷第5期
    • 作者机构：

      1. Biosafety Level-3 Laboratory, Life Sciences Institute & Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Collaborative Innovation Center for Biomedicine, Guangxi Medical University,Guangxi,Nanning,PR China,530021

      2. Fourth People's Hospital of Nanning,Guangxi,Nanning,PR China,530024

      3. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University,Guangdong,Guangzhou,PR China,510515

    • DOI：10.1016/j.gendis.2021.12.005    

      中图分类号：

    • 纸质出版日期：2022，

      网络出版日期：2022-9-1，

    扫 描 看 全 文

  • Sanqi An, Zhouhua Xie, Yanyan Liao, 等. Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients[J]. Genes & Diseases, 2022,9(5). DOI： 10.1016/j.gendis.2021.12.005.

    Sanqi An, Zhouhua Xie, Yanyan Liao, et al. Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients[J]. Genes & Diseases, 2022,9(5). DOI： 10.1016/j.gendis.2021.12.005.

  •  
  •  
查看原文

0

浏览量

0

下载量

0

CSCD

文章被引用时，请邮件提醒。
提交
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据
0